← Eichor
Study identifier: NCT07527104 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial Hemorrhage

Condition: Cerebral Palsy Hypoxic-Ischemic Encephalopathy Intracranial Hemorrhage  ·  Sponsor: National Children's Hospital, Vietnam

PhaseNA
Planned participants60
Who can joinAll sexes, 6 Months to 18 Years
Healthy volunteersNo

About this study

This study evaluates the safety and preliminary efficacy of autologous bone marrow mononuclear cell transplantation combined with rehabilitation in children with neurological sequelae caused by hypoxic-ischemic brain injury or intracranial hemorrhage. Participants in the intervention group will receive autologous bone marrow aspiration, mononuclear cell transplantation via intrathecal route, and rehabilitation, while the control group will receive rehabilitation alone. Outcomes will be compared between groups over follow-up time points.

This description comes directly from the study's public registry record.

Talk to the study team

DAT HUU TRAN  ·  +84987836686  ·  drtrandat1986@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Vietnam National Children's HospitalHanoi, Hanoi, VietnamRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07527104